TRIUS THERAPEUTICS
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. We have successfully completed two Phase 3 clinical trials for Tedizolid Phosphate (TR-701), formerly torezolid phosphate, in ABSSSI. Tedizolid is an IV and orally administered second generation oxazolidinone, for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staph... ylococcus aureus (MRSA). With the continuous increase in bacterial resistance to currently marketed drugs, serious infections are becoming more difficult, if not impossible to treat, and this has led to a clear need for novel therapeutics to treat multi-drug resistant bacterial infections. Trius is headquartered in San Diego, California. We have built a strong management team with significant development and regulatory experience. Our senior management team consists of nine individuals who collectively have been involved in the development and approval of a significant number of anti-infective drugs.
TRIUS THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care
Founded:
2004-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.triusrx.com
Total Employee:
1001+
Status:
Closed
Contact:
8586779975
Total Funding:
99.25 M USD
Technology used in webpage:
Euro Nginx OpenResty Google Adsense Google Adsense For Domains IIS 6 Time Warner LeaseWeb Omniture SiteCatalyst Charter Communications
Similar Organizations
BiomeHub
BiomeHub focuses on the development of innovative healthcare services.
Nexcida Therapeutics
Nexcida Therapeutics develops a novel antibiotics to treat serious, life-threatening bacterial infections.
Saegis Pharmaceuticals
Saegis Pharmaceuticals is focused on the development of medicines that address behavioral disorders.
Zolex Therapeutics
Zolex Therapeutics focuses on the development of new classes of orally-active antibiotics to combat life-threatening bacterial infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Versant Ventures
Versant Ventures investment in Series A - Trius Therapeutics
InterWest Partners
InterWest Partners investment in Series A - Trius Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series A - Trius Therapeutics
Tech Coast Angels
Tech Coast Angels investment in Venture Round - Trius Therapeutics
Official Site Inspections
http://www.triusrx.com
- Host name: 172.67.140.74
- IP address: 172.67.140.74
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Trius Therapeutics"
Trius Therapeutics 2025 Company Profile: Valuation, …
Trius Therapeutics General Information Description. Operator of a biopharmaceutical company based in San Diego, California. The company's …See details»
Trius Therapeutics - Crunchbase Company Profile & Funding
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections.See details»
Trius Therapeutics - VentureRadar
Open PageRank: 6,498,552 | triusrx.com. VentureRadar Popularity. Medium. VentureRadar Popularity: Medium. The popularity score combines profile views, clicks and the number of …See details»
Working At triusrx.com: Company Overview and Culture - Zippia
May 18, 2020 Learn about working at triusrx.com from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. Find out what it's like to …See details»
Trius Therapeutics, Inc. - Drug pipelines, Patents, Clinical ... - Patsnap
Triusrx.com. Private Company | Subsidiary Company | 2004 | Massachusetts, United States | 1,000-5,000 | NASDAQ: TSRX | triusrx.com. Last update 07 Mar 2025. Overview. Pipeline. ...See details»
About Trius Therapeutics Inc (TSRX) - Investing.com
This page offers an in-depth profile of Trius Therapeutics Inc, including a general overview of the company's business and key management.See details»
Trius Therapeutics - Overview, News & Similar companies
View Trius Therapeutics (www.triusrx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Trius Therapeutics LLC in San Diego, CA - (858) 452-0370 - Profile
Trius Therapeutics LLC is in the Antibiotics, Packaged business. View competitors, revenue, employees, website and phone number.See details»
Trius Therapeutics - Owler
Trius Therapeutics’s Profile, Revenue and Employees. Trius Therapeutics is a biopharmaceutical company focused on the development of antibiotics. Trius Therapeutics’s primary competitors …See details»
The Redd Organization is Coming With Two Launches - TriusRx
Sep 19, 2024 ReddCoin is gaining positive ground and ReddCoin has declared that they will launch their portable wallet & another form of ReddID v1.0.See details»
Trius Therapeutics and Bayer Form Strategic Collaboration
Jul 27, 2011 For more information, visit www.triusrx.com. About Bayer HealthCare. The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and …See details»
Cubist Pharmaceuticals, Inc. Completes Acquisition of Trius ...
Sep 12, 2013 Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics. LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) …See details»
Trius Therapeutics, Inc. | Insights
Mar 19, 2018 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Trius Therapeutics: TSRX IPO, Health Care - Developing an …
Aug 2, 2010 Trius Therapeutics , Nasdaq: TSRX. Developing an antibiotic for serious gram-positive Staph infections. Industry: Health CareSee details»
Trius Therapeutics Awarded $28 Million Contract to Develop Novel ...
Oct 22, 2008 Trius Therapeutics Awarded $28 Million Contract to Develop Novel Antibiotics SAN DIEGO, Oct. 22 /PRNewswire/ -- Trius Therapeutics, Inc., today announced the award of a …See details»
Blockchain Payment Company BitPay Achieves Soc 2 Compliance
Sep 19, 2024 BitPay declared that it has passed the Service Organization Control Review (SOC 2) led by the Aprio, which is among the top 100 CPA led advisory firms.See details»
Trius Therapeutics, Inc. (Trius Therapeutics, Inc.) - 药物管线_专利_ …
了解Trius Therapeutics, Inc. (Trius Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 7篇新闻和28篇文献，药物:磷酸特地唑胺，Rx-101005，R-701。See details»
Announce the Close of Dash Latam in Latin America & Venezuela
Sep 12, 2024 Dash Latam in Venezuela & Latin America, offer support to the traders, the closure of the activities in the region through face-to-face and remote mode.See details»
Sritanshu Sinha | Author at TriusRx
Oct 7, 2024 Sritanshu is active in the crypto ecosystem and has broad experience in content strategy, journalism, and PR. He is involved in the crypto scene in India, and passion for …See details»